Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2023-08-04 00:00:00 ET · period of report 2023-08-02 · accession 0001735276-23-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-04 | 2023-08-03 | ALNY | BONNEY MICHAEL W | Dir | S - Sale+OE | $185.38 | -6,448 | 16.5K | -28% | -$1.20M |
| D | 2023-08-04 | 2023-08-02 | ALNY | BONNEY MICHAEL W | Dir | M - OptEx | $0.00 | +22.5K | 22.5K | New | $0 |
| D | 2023-08-04 | 2023-08-02 | ALNY | BONNEY MICHAEL W | Dir | M - OptEx | $0.00 | -22.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-03 | S | D | 1,714 | $185.99 | 17,868 | D | — | — | (F6) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.49 to $186.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2023-08-03 | S | D | 450 | $187.71 | 16,029 | D | — | — | (F8) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.58 to $187.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 3 | Common | Common Stock | 2023-08-03 | S | D | 560 | $183.75 | 21,117 | D | — | — | (F4) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $183.20 to $184.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 4 | Common | Common Stock | 2023-08-03 | S | D | 500 | $182.45 | 21,677 | D | — | — | (F3) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $182.13 to $183.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 5 | Common | Common Stock | 2023-08-03 | S | D | 300 | $181.08 | 22,177 | D | — | — | (F2) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $181.00 to $181.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 6 | Common | Common Stock | 2023-08-03 | S | D | 1,535 | $184.89 | 19,582 | D | — | — | (F5) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.48 to $185.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 7 | Common | Common Stock | 2023-08-03 | S | D | 1,389 | $187.04 | 16,479 | D | — | — | (F7) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.53 to $187.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 8 | Common | Common Stock | 2023-08-02 | M | A | 22,477 | $0.00 | 22,477 | D | — | — | |
| 9 | Derivative | Restricted Stock Units | 2023-08-02 | M | D | 22,477 | $0.00 | 0 | D | — · — to — | 22,477 Common Stock | (F10) Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. (F11) The restricted stock units vest in full on the second anniversary of the grant date, August 2, 2021, provided the Reporting Person continues to serve as a director through such anniversary date, or earlier than such anniversary date if he ceases to serve as a director other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors. |